Download
slide1 n.
Skip this Video
Loading SlideShow in 5 Seconds..
North American Erythropoietin Biologic and Biosimilar Drug Market PowerPoint Presentation
Download Presentation
North American Erythropoietin Biologic and Biosimilar Drug Market

North American Erythropoietin Biologic and Biosimilar Drug Market

156 Views Download Presentation
Download Presentation

North American Erythropoietin Biologic and Biosimilar Drug Market

- - - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript

  1. North American Erythropoietin Biologic and Biosimilar Drug Market to decline at a five-year CAGR of 0.9% by 2020, says a New Research Report at Ceskaa Research ============================================================== Madison, NJ | Dec 17, 2015 | Ceskaa Research Ceskaa Market Research (http://www.ceskaa.com/shop/new-research-2/global-market-for-erythropoietin- report-2015-2020/) has announced the addition of the Global Erythropoietin Market: 2015-2020 report to their offering. The North America erythropoietin market has been primarily dominated by biologic drugs in the U.S. and Canada and by biosimilar drugs in Mexico. The U.S. dominates the North American erythropoietin drug market followed by Canada and Mexico. The major players in the biologic erythropoietin drug market are, Amgen, Johnson & Johnson and Hoffmann-LA Roche. This market research report explain current market for erythropoietin drugs in terms of value. The report also highlights the major drivers and challenges, including their profiles related to erythropoietin drugs. The North American market for erythropoietin biologic and biosimilar drugs has been declining at a CAGR (2015 to 2020) of 0.9% primarily due to the patent expiry of EPO biologic drugs. The North American market for erythropoietin biologic and biosimilar drugs is expected to grow at a year-on-year (YOY) growth rate of 11.2%. In addition, the market is expected to decline at a five-year CAGR (2015 to 2020) of 0.9%, by 2020.

  2. TABLE VALUE FORECAST: NORTH AMERICA EPO DRUG MARKET BY DRUG NAME, THROUGH 2020 ($ MILLIONS) 5 Year CAGR (2015-2020) - DRUG NAME 201420152020 Epogen - - - Procrit - - - - - - - - - NeoRecormon Total - - - - - - - - - - - - - - - - Source: Ceskaa Research This report could be used for, but not limited to, the following reasons: Gain an overview of the North American market for Erythropoietin biologic and biosimilar market by drug. Gain an overview on the major players in the U.S., Canada and Mexico EPO biosimilar market by market share. Analyse the North American erythropoietin drug market on the basis of its application with data from 2014, estimates for 2015, and projections of CAGRs through 2020. Evaluate the market's dynamics such as growth drivers, challenges and trends. Analysis of major players in the erythropoietin drug market with SWOT for major public companies. TABLE VALUE FORECAST: MEXICO EPO MARKET BY DRUG, THROUGH 2020 ($ MILLIONS) 5 Year CAGR (2015-2020) - DRUG 201420152020 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Source: Ceskaa Research

  3. TABLE OF CONTENT CHAPTER: ONE INTRODUCTION OBJECTIVES SCOPE DATA SOURCES DISCLAIMER CHAPTER: TWO CHAPTER: THREE SUMMARY OVERVIEW DEFINITION EPO DRUG BY TYPE BIOLOGICS Epoietin-alfa Epoietin-beta Darbepoietin-alfa Others BIOSIMILARS Epoietin-zeta Epoietin-omega Others APPLICATION End stage renal disease Pre-dialysis Oncology Others SIDE EFFECTS OF ERYTHROPOIETIN CHAPTER: FOUR FORECASTING GLOBAL ERYTHROPOIETIN MARKET Global EPO Biologics Drugs Global EPO Biosimilars Drugs EPO BIOLOGIC DRUG MARKET BY TYPE Epoietin-alfa

  4. Epoietin-beta Darbepoietin-alfa Others EPO BIOLOGIC MARKET BY DRUG Epogen Procrit Eprex Mircera NeoRecromon Aranesp Others EPO BIOSIMILAR MARKET BY DRUG Retacrit Binocrit Abseamed EPIAO HEMAX Epoetin-alfa BS Xue Da Sheng Others EPO BIOSIMILARS DRUG MARKET BY TYPE Epoetin-zeta Epoetin-omega Others EPO DRUG MARKET BY HALF LIFE Long Acting EPO Short Acting EPO GLOBAL EPO DRUG MARKET BY APPLICATION End Stage Renal Disease (ESRD) Oncology Diseases Pre-dialysis Others GLOBAL EPO MARKET SEGMENTATION, BY GEOGRAPHY North America Europe Asia pacific South America ROW GLOBAL EPO NORTH AMERICAN MARKET SUB-SEGMENTATION The U.S Mexico Canada

  5. GLOBAL EPO EUROPE MARKET SUB-SEGMENTATION EU-5 Nordic Russia Others GLOBAL EPO ASIA-PACIFIC MARKET SUB-SEGMENTATION China India Japan Australia Others GLOBAL EPO SOUTH AMERICAN MARKET SUB-SEGMENTATION Brazil Argentina Others CHAPTER: FIVE PATENTS AND R & D PIPELINE CHAPTER: SIX DRIVERS INCREASING CASES ESRD GLOBAL DIALYSIS PATIENT POPULATION INCREASING PREVALENCE OF CANCER UPCOMING PATENT EXPIRIES OF ORIGINAL BIO DRUGS CHAPTER: SEVEN CHALLENGES INCREASING CONCERNS OVER RISK OF THROMBOSIS AND PRCA INCREASING COMPETITION FROM OTHER ALTERNATIVE DRUGS CHAPTER: EIGHT SUPPLIERS LANDSCAPE AND COMPANY PROFILES SUPPLIER LANDSCAPE COMPANY PROFILES 3S BIO AMEGA BIOTECH AMGEN APPOLLO PHARMACEUTICALS

  6. ASTRA ZENECA BEIJING SIHUAN BIOCON (INDIA) BIOSIDUS BLAUSEIGEL CENTER OF MOLECULAR IMMUNOLOGY CELON LABS CHALVER LABORATORIES CHENDU DIAO CJ HEALTH CARE CLARIS LIFESCIENCES CRYOPHARMA DR. REDDYS LABS EBIOSCIENCE ETHNOR EMCURE PHARMACEUTICALS FERON LIFESCIENCES HAYAO BIOLOGICAL HINDUSTAN ANTIBIOTICS HOSPIRA INCEPTA PHARMACEUTICALS INTAS PHARMACEUTICALS JCR PHARMA JOHNSON & JOHNSON KISSEI PHARMACEUTICAL KLARVOYANT BIOGENICS KYOWA HAKKO LANDSTEINER LA RENON HEALTHCARE LG LIFE SCIENCES INDIA LUPIN MEDICE ARZNEIMITTEL MICRO LABS NANOGEN BIOPHARMACEUTICAL NOVARTIS PANACEA BIOTEC PISA PROBIOMED RELIANCE FORMULATION ROCHE RPG LIFE SCIENCES SEPTALYST LIFESCIENCES SERUM INSTITUTE OF INDIA SHANDONG KEXING BIOPRODUCTS SHANGHAI CHEMO SHANTHA BIOTECHNICS STADA ARZENEIMITTEL SUN PHARMACEUTICALS TAJ PHARMACEUTICALS

  7. TEVA VHB LIFE SCIENCES VIFOR PHARMA WOCKHARDT ZUVENTUS HEALTH CARE ZYDUS CADILA HEALTHCARE LIST OF TABLES: TABLE: 01 VALUE FORECAST: GLOBAL EPO DRUG MARKET, THROUGH 2020 ($ MILLIONS) TABLE: 02 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY CATEGORY, THROUGH 2020 ($ MILLIONS) TABLE: 03 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY REGION, THROUGH 2020 ($ MILLIONS) TABLE: 04 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY APPLICATIONS, THROUGH 2020 ($ MILLIONS) TABLE: 05 VALUE FORECAST: GLOBAL EPO DRUG MARKET BY TYPE, THROUGH 2020 ($ MILLIONS) Click here to download entire ‘list of tables’. LIST OF FIGURES: FIGURE: 01 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET, 2015 AND 2020 (%) FIGURE: 02 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY CATEGORY, 2015 AND 2020 (%) FIGURE: 03 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY REGION, 2015 AND 2020 (%) FIGURE: 04 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY APPLICATIONS, 2015 AND 2020 (%) FIGURE: 05 MARKET SHARE BY VALUE: GLOBAL EPO DRUG MARKET BY TYPE, 2015 AND 2020 (%) Click hereto download entire ‘list of figures’.

  8. About Ceskaa Research: Ceskaa is a boutique market research company serving the global markets. We offer high quality market research reports on various industries. Our strong primary and secondary research teams are committed to assure the best market research reports and precise market data for your consideration. Our research report provide useful insights, such as present and future market, competitive landscape, drivers, challenges, trends and pricing, which will help you to identify the opportunities and develop profitable business strategies. In-short the goal is to serve information you desire for a better decision making. Ceskaa provide reports on 12 industries, which in are as follows: Advanced Material Automation & Control Process Biotechnology Chemical Electronics and Semiconductor Energy and Power Engineering & Manufacturing Food & Beverage Healthcare IT & Telecom Pharmaceutical Plastics For more information visit: http://www.ceskaa.com/shop/new-research-2/global-market-for- erythropoietin-report-2015-2020/ Contact: Tisha Thomas Email: tisha@ceskaa.com Phone: +1 973-805-7440 Website: https://ceskaa.com/ Source: Ceskaa Research